Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0001193125-26-022557

Chief Legal Officer sold 1,371 shares at $34.00 ($46,614)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bellon Christine · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-22 Sale : show line 1 in the form 10b5-1 −1,371 $34.00 $46,614 95,667 D
Open-market sales · 1,371 sh · avg $34.00 · $46,614
Loading xslF345X05/ownership.xml…